Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)

Osteoarthritis Pain Clinical Trial

Official title:
A Randomized, Double Blind, Placebo Controlled, Crossover Clinical Trial to Evaluate the Effects of ATP-Induced Pain (AIP) and ATP-induced Dermal Vasodilation (AIDV) by Iontophoresis in Healthy Subjects

Status Completed

Clinical Trial Summary

This study will evaluate ATP-induced Pain (AIP) and ATP-induced dermal vasodilation (AIDV) as target engagement tools for future development of analgesics.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Osteoarthritis Pain

Clinical Trial Details

NCT number	NCT00917696
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 1
Start date	October 2009
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01780389` - Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)	Phase 4
Terminated	`NCT05008835` - Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee	Phase 2
Completed	`NCT04296344` - Group Acupuncture Therapy With Modified Yoga	N/A
Completed	`NCT01980940` - The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)	Phase 1/Phase 2
Completed	`NCT01030640` - Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected	Phase 1